In a retrospective study, patients with prior use of GLP-1 receptor agonists showed a significantly lower risk of developing ...

GLP-1 receptor agonist (RA) prescribing increased from 0.2 to 6.4 per 1000 deliveries predelivery and from 0.3 to 14.6 per 1000 deliveries postdelivery between 2019 and 2024. Among recipients in 2024, ...

Apogee Therapeutics develops RORγt-targeted therapies as Nasdaq today highlights clinical-stage biotech activity.

Vanda Pharmaceuticals said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health ...

Amazon Pharmacy maintains the requirement for a valid prescription as the central safeguard separating evidence-based medical ...

Potential blockbusters and root-cause treatments from Eli Lilly, Merck, Takeda and others could get a regulatory nod this ...

From December 4 to 6, 2025, the 5th International Cough Conference (ICC) was successfully held in Guangzhou, China. This ...

Lupin had earlier indicated that the transaction of the Amsterdam-based firm would be consummated by the end of the calendar year 2025. Shares of Lupin Ltd ended at ₹2,080.40, down by ₹1.70, or 0.082% ...

In a major boost for health research, 22 UQ researchers and teams have secured $29 million from the National Health and ...

Genetics play a role in low testosterone for some men, but underlying causes vary widely. Many genes influence testosterone ...

In a paper published in aBIOTECH, the authors introduce NLRSeek, a reannotation-based pipeline for comprehensive mining of ...